Exactech sources cartilage technology from Taiwan
This article was originally published in Clinica
Exactech, the Gainesville, Florida-based developer and producer of bone and joint restoration products, is planning to launch a cartilage repair programme that will include a device for the treatment and repair of cartilage in the knee joint. The move follows an exclusive licensing agreement between Exactech's subsidiary Exactech Taiwan, the Taiwanese Industrial Technology Research Institute and the National Taiwan University Hospital. The terms of the agreement call for a licence fee based on the achievement of specific regulatory milestones and a sales-based royalty once the product is marketed.
You may also be interested in...
Health technology assessment body NICE says that Revlimid fights cancer cells in a different way to current treatments which should help reduce resistance and improve disease outcomes.
As sector awaits its aducanumab filing with bated breath, Biogen invests again in early stage neuroscience.
In case you missed it: catch up with snippets from interviews with industry leaders recently published by In Vivo.